Skip to content

Design Therapeutics

US · DSGN #3479 by market cap Listed 2021
11.38 -0.31 -2.65%
Live - 5344 symbols - heartbeat 88s ago · 2026-10-08 09:56
Pre-market 11.81 +1.03%
After-hours 11.69 0.00%
Market cap
712.18M
P/B
3.53
EPS
-1.22
Reader sentiment Are you bullish or bearish on DSGN?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 3 analysts

Buy
Avg price target 22.67 +99.2%
Price target rangecurrent 11.38
Low20.00
Avg22.67
High26.00
Buy 100% Hold 0% Sell 0%
Recent ratings (18)
DateFirmAnalystRatingTarget
2026-10-02 Wells Fargo -- BUY 26.00
2026-08-04 Craig-Hallum -- BUY 22.00
2026-08-03 RBC Capital -- BUY 20.00
2026-06-15 Oppenheimer -- BUY 21.00
2026-05-27 Piper Sandler -- BUY 20.00
2026-05-19 Craig-Hallum -- BUY 22.00
2026-05-18 RBC Capital -- BUY 20.00
2026-05-04 Oppenheimer -- BUY 21.00
2026-04-29 Craig-Hallum -- BUY 15.00
2026-04-29 Piper Sandler -- BUY 20.00
2026-04-28 RBC Capital -- BUY 14.00
2026-03-15 Jefferies -- BUY 15.00
2026-03-10 Craig-Hallum -- BUY 15.00
2026-03-10 Oppenheimer -- BUY 18.00
2026-01-07 Oppenheimer -- BUY 18.00
2025-12-03 Craig-Hallum -- BUY 15.00
2025-12-03 Leerink Partners -- BUY 14.00
2025-11-20 RBC Capital -- BUY 13.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q1 2026-04-28 After close ±38.25% +23.26% (in line)
2023/Q4 2024-03-19 After close -- +11.97%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-08 09:56:28 · For reference only, not investment advice and not tailored to your situation.